Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 241

1.

Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.

Gkika E, Adebahr S, Kirste S, Schimek-Jasch T, Wiehle R, Claus R, Wittel U, Nestle U, Baltas D, Grosu AL, Brunner TB.

Strahlenther Onkol. 2017 Jan 30. doi: 10.1007/s00066-017-1099-8. [Epub ahead of print]

PMID:
28138949
2.

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, Magliocco A, Bredel M, Robe P, Grosu AL, Stupp R, Curran W Jr, Becker AP, Salavaggione AL, Barnholtz-Sloan JS, Aldape K, Blumenthal DT, Brown PD, Glass J, Souhami L, Lee RJ, Brachman D, Flickinger J, Won M, Chakravarti A.

JAMA Oncol. 2017 Jan 12. doi: 10.1001/jamaoncol.2016.6020. [Epub ahead of print]

PMID:
28097324
3.

Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.

Zamboglou C, Drendel V, Jilg CA, Rischke HC, Beck TI, Schultze-Seemann W, Krauss T, Mix M, Schiller F, Wetterauer U, Werner M, Langer M, Bock M, Meyer PT, Grosu AL.

Theranostics. 2017 Jan 1;7(1):228-237. doi: 10.7150/thno.16638.

4.

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M; DKTK-ROG..

Radiother Oncol. 2016 Dec;121(3):364-373. doi: 10.1016/j.radonc.2016.11.008.

PMID:
27913065
5.

Re-irradiation for Recurrent Primary Brain Tumors.

Nieder C, Andratschke NH, Grosu AL.

Anticancer Res. 2016 Oct;36(10):4985-4995. Review.

PMID:
27798857
6.

Simultaneous integrated protection : A new concept for high-precision radiation therapy.

Brunner TB, Nestle U, Adebahr S, Gkika E, Wiehle R, Baltas D, Grosu AL.

Strahlenther Onkol. 2016 Dec;192(12):886-894.

7.

Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).

Oehlke O, Mix M, Graf E, Schimek-Jasch T, Nestle U, Götz I, Schneider-Fuchs S, Weyerbrock A, Mader I, Baumert BG, Short SC, Meyer PT, Weber WA, Grosu AL.

BMC Cancer. 2016 Oct 5;16(1):769.

8.

Single punch, double biopsy.

Krönig M, Nanko N, Drendel V, Werner M, Schultze-Seemann W, Grosu AL, Jilg AC.

Springerplus. 2016 Aug 30;5(1):1456. doi: 10.1186/s40064-016-3141-1.

9.

Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.

Bittner MI, Wiedenmann N, Bucher S, Hentschel M, Mix M, Rücker G, Weber WA, Meyer PT, Werner M, Grosu AL, Kayser G.

Acta Oncol. 2016 Nov;55(11):1299-1304.

PMID:
27593107
10.

Prospective randomized clinical studies involving reirradiation : Lessons learned.

Nieder C, Langendijk JA, Guckenberger M, Grosu AL.

Strahlenther Onkol. 2016 Oct;192(10):679-86. doi: 10.1007/s00066-016-1024-6. Review.

PMID:
27534408
11.

Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer.

Zamboglou C, Rischke HC, Meyer PT, Knobe S, Volgeova-Neher N, Kollefrath M, Jilg CA, Grosu AL, Baltas D, Kroenig M.

J Contemp Brachytherapy. 2016 Jun;8(3):241-8. doi: 10.5114/jcb.2016.61067.

12.

Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications.

Popp I, Grosu AL, Niedermann G, Duda DG.

Radiother Oncol. 2016 Aug;120(2):185-94. doi: 10.1016/j.radonc.2016.07.013. Review.

PMID:
27495145
13.

(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison.

Zamboglou C, Schiller F, Fechter T, Wieser G, Jilg CA, Chirindel A, Salman N, Drendel V, Werner M, Mix M, Meyer PT, Grosu AL.

Theranostics. 2016 Jun 18;6(10):1619-28. doi: 10.7150/thno.15344.

14.

Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies.

Jing H, Weidensteiner C, Reichardt W, Gaedicke S, Zhu X, Grosu AL, Kobayashi H, Niedermann G.

Theranostics. 2016 Apr 12;6(6):862-74. doi: 10.7150/thno.12890.

15.

Customized treatment of recurrent gynaecological cancer--the need for intraoperative radiation therapy.

Lambers K, Hasenburg A, Stickeler E, Gitsch G, Grosu AL, Henne K, Farthmann J.

Eur J Gynaecol Oncol. 2016;37(1):48-52.

PMID:
27048109
16.

MRI and FDG-PET/CT imaging in gynecological malignancies: the radiation oncology perspective.

Fennell J, Scholber J, Grosu AL, Volegova-Neher N, Henne K, Langer M, Meyer PT, Gitsch G, Bartl N.

Q J Nucl Med Mol Imaging. 2016 Jun;60(2):117-23. Review.

17.

Predicted survival in patients with brain metastases from colorectal cancer: Is a current nomogram helpful?

Nieder C, Hintz M, Grosu AL.

Clin Neurol Neurosurg. 2016 Apr;143:107-10. doi: 10.1016/j.clineuro.2016.02.022.

PMID:
26914143
18.

Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.

Tinhofer I, Budach V, Saki M, Konschak R, Niehr F, Jöhrens K, Weichert W, Linge A, Lohaus F, Krause M, Neumann K, Endris V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Baumann M; DKTK-ROG..

Eur J Cancer. 2016 Apr;57:78-86. doi: 10.1016/j.ejca.2016.01.003.

PMID:
26896955
19.

PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases.

Rischke HC, Eiberger AK, Volegova-Neher N, Henne K, Krauss T, Grosu AL, Jilg CA.

Adv Med Sci. 2016 Sep;61(2):212-218. doi: 10.1016/j.advms.2016.01.003.

PMID:
26895459
20.

Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases.

Bilger A, Milanovic D, Lorenz H, Oehlke O, Urbach H, Schmucker M, Weyerbrock A, Nieder C, Grosu AL.

Clin Neurol Neurosurg. 2016 Mar;142:81-6. doi: 10.1016/j.clineuro.2016.01.008.

PMID:
26816106
Items per page

Supplemental Content

Loading ...
Support Center